Recent Headlines
- Beleave CRO Appointment and Approval of Stalking Horse Sale Process
- Beleave Granted Creditor Protection to Pursue Sale of Assets
- IIROC Trade Resumption - BE
- Beleave To Seek Creditor Protection to Pursue Sale of Assets
- IIROC Trading Halt - BE
- Imagine Owning Beleave (CSE:BE) And Taking A 97% Loss Square On The Chin
- IIROC Trade Resumption - BE
- Beleave Refiles Amended and Restated MD&A and Financial Statements
- Beleave Files Amended and Restated Financial Statements
- IIROC Trading Halt - BE
- Beleave's Q3 Financials Should Not Be Relied Upon
- IIROC Trading Halt - BE
- Beleave Provides Operational and Leadership Updates
- Beleave Enters LOI with Dutchman's Gold to Partner on Cannabis Infused Honey Products
- Beleave Announces Approval for Sales in Alberta
- Beleave Expands Cannabis 2.0 Product Roll Out to British Columbia with Flyte Classic Vaporizer
- Beleave Announces Consulting Agreement with Shaxon Enterprises
- IIROC Trade Resumption - BE
- Beleave Receives Purchase Order for Cannabis 2.0 Products and Provides Other Operational Updates
- Beleave Provides Update on Company Leadership
- IIROC Trading Halt - BE
- Beleave Announces Election of Board of Directors and AGM 2019 Summary
- Beleave Announces AGM Conference Call Details
- Beleave Announces Joint Venture with Volero Brands to Launch Cannabis 2.0 Products in Canada
- Beleave Receives License to Sell Cannabis Extracts, Topicals and Edibles
- Beleave Announces Date of 2019 Annual General Meeting
- Beleave Appoints Jeannette VanderMarel to Board of Directors
- Beleave Appoints Jeannette VanderMarel Chief Executive Officer
- Beleave Provides Bi-Weekly Default Status Update
- Beleave Announces Operational Updates and Q1 2019 Financials Release Date
- Beleave Provides Bi-Weekly Default Status Update
- Beleave Announces LOI for Leaseback of London Production Facility and Sale of Lloydminster Retail Space
- Beleave Provides Bi-Weekly Default Status Report
- Beleave's New Research License Allows for Further Optimization of Cannabinoids for Capsules and Edibles
- Beleave Announces Sale of Popular Blue Dream Strain
- Beleave Granted Management Cease Trade Order
- IIROC Trade Resumption - BE
- Beleave Announces Non-Binding LOI with TerraFarma Inc.
- Beleave Announces Delay in Filing of Audited Financials
- Beleave Announces Delay in Filing of Audited Financials
- IIROC Trading Halt - BE
- Beleave Commences Sales of Cannabis Oils for the Canadian Adult Use Market
- Beleave Releases Restated Financials with 7% Revenue Increase for the Nine Months Ended December 31, 2018
- Beleave Expands Recreational Cannabis Sales to Saskatchewan
- IIROC Trade Resumption - BE
- Beleave Receives Green Light for Building Permit as Hamilton Phase 2 Expansion Moves Forward
- IIROC Trading Halt - BE
- Beleave Updates Prior Disclosure and Announces Approval of Settlement Agreement with the BCSC
- Beleave Expands Product Line with New Beleave-Branded Product Shipped to the OCS
- Beleave Receives Approval for Hamilton Facility Expansion from City Council